Inactive
Notice ID:36E79723R0039
The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0039 for an unrestricted procurement for Oseltamivir Suspension and Capsules for the Department of Veterans Affa...
The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0039 for an unrestricted procurement for Oseltamivir Suspension and Capsules for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC or UPC number that is unique to the offeror. Solicitation #36E79723R0039 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 9, 2023, with a tentative closing date of October 23, 2023. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to: Youlanda.Duggar@va.gov. The estimated annual requirements are as follows: ITEM DESCRIPTION PKG SIZE TOTAL EST ANNUAL USAGE (Per Bottle) (Bottles) 1 OSELTAMIVIR PO4 30MG CAP 10 Caps 10,488 2 OSELTAMIVIR PO4 45MG CAP 10 Caps 2,123 3 OSELTAMIVIR PO4 75MG CAP 10 Caps 81,760 4 OSELTAMIVIR PO4 6MG/ML SUSP 60mL 34, 341 For line items 1 through 3 (capsules), product may be provided either in blister packs or bottles. If provided in bottles, the bottles must meet Unit of Use size requirements. All unit of use bottles must contain a child proof closure (safety cap) and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and maximum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . Glass Bottles are not acceptable for line items 1 through 3, but are acceptable for line item 4 (suspension).
